Supplemental material
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 21, 2021 - Issue 1
Original Research
The burden of productivity loss of U.S. commercially insured patients diagnosed with Dupuytren’s disease undergoing collagenase versus fasciectomy treatment
Djurdja Vukicevica HEOR Department, ZRx Outcomes Research Inc, Mississauga, ON, Canada
https://orcid.org/0000-0001-9591-1111View further author information
https://orcid.org/0000-0001-9591-1111View further author information, Simona Tatovica HEOR Department, ZRx Outcomes Research Inc, Mississauga, ON, Canadahttps://orcid.org/0000-0002-5682-774XView further author information
https://orcid.org/0000-0002-5682-774XView further author information, Vladimir Zaha HEOR Department, ZRx Outcomes Research Inc, Mississauga, ON, CanadaCorrespondence[email protected]
https://orcid.org/0000-0003-1368-4491View further author information
https://orcid.org/0000-0003-1368-4491View further author information, David Hurleyb Medical Department, Endo Pharmaceuticals Inc, Malvern, PA, USAhttps://orcid.org/0000-0001-9946-7572View further author information
https://orcid.org/0000-0001-9946-7572View further author information & Martina Imroa HEOR Department, ZRx Outcomes Research Inc, Mississauga, ON, Canadahttps://orcid.org/0000-0003-0440-9375View further author information
https://orcid.org/0000-0003-0440-9375View further author information